Held in Athens, this event focuses on cutting-edge research and practices improving acute cardiovascular care. Dive into expert-led sessions exploring novel treatment protocols, patient management strategies, and technology-driven solutions in cardiology. Our team will present our contributions to enhancing patient outcomes in acute care. Don’t miss the chance to collaborate with global cardiology leaders. Schedule a meeting with us to exchange ideas and discuss potential partnerships.
Five Years Since a World-First CRISPR Breakthrough at Richmond Pharmacology
December 8, 2025
In November 2020, Richmond Pharmacology made medical history when a patient received the first-ever systemically delivered CRISPR therapy, using lipid nanoparticles to edit genes directly inside the human body.
Richmond Pharmacology will attend JSCPT 2025 in Tokyo, represented by their leadership team. Topics include early-phase studies, bridging studies between Europe and Asia, gene and RNA-based therapy development, and cross-border collaboration.
By clicking “Accept”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. View our Privacy Policy for more information.
.svg){kind=small}
.avif)
